Genprex Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
GNPX$2.06-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Changes in Stockholders’ Equity
| Common Stock | |||||
|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | Accumulated Deficit | Total | |
| Balance at December 31, 2021 | 1,196,893 | 1,197 | 120,362,992 | (79,087,198) | 41,276,991 |
| Issuance of common stock for cash | 3,023 | 3 | 6,423 | — | 6,426 |
| Issuance of common stock for services | 2,761 | 3 | 163,229 | — | 163,232 |
| Share-based compensation | — | — | 4,568,712 | — | 4,568,712 |
| Net loss | — | — | — | (23,740,621) | (23,740,621) |
| Balance at December 31, 2022 | 1,202,677 | 1,203 | 125,101,356 | (102,827,819) | $22,274,740 |
| Issuance of common stock and warrants for cash net of issuance costs | 282,725 | 282 | 10,593,095 | — | 10,593,377 |
| Issuance of common stock for services | 500 | 1 | 19,009 | — | 19,010 |
| Share-based compensation | — | — | 5,389,718 | — | 5,389,718 |
| Net loss | — | — | — | (30,860,461) | (30,860,461) |
| Balance at December 31, 2023 | 1,485,902 | 1,486 | 141,103,178 | (133,688,280) | $7,416,384 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.